BACKGROUND: Granulomatosis with polyangiitis (GPA), formerly known as Wegener's granulomatosis (WG), belongs to the group of ANCA-associated necrotizing vasculitides. This study describes the clinical picture of the disease in a large cohort of GPA paediatric patients. Children with age at diagnosis ≤ 18 years, fulfilling the EULAR/PRINTO/PRES GPA/WG classification criteria were extracted from the PRINTO vasculitis database. The clinical signs/symptoms and laboratory features were analysed before or at the time of diagnosis and at least 3 months thereafter and compared with other paediatric and adult case series (>50 patients) derived from the literature. FINDINGS: The 56 children with GPA/WG were predominantly females (68%) and Caucasians (82%) with a median age at disease onset of 11.7 years, and a median delay in diagnosis of 4.2 months. The most frequent organ systems involved before/at the time of diagnosis were ears, nose, throat (91%), constitutional (malaise, fever, weight loss) (89%), respiratory (79%), mucosa and skin (64%), musculoskeletal (59%), and eye (35%), 67% were ANCA-PR3 positive, while haematuria/proteinuria was present in > 50% of the children. In adult series, the frequency of female involvement ranged from 29% to 50% with lower frequencies of constitutional (fever, weight loss), ears, nose, throat (oral/nasal ulceration, otitis/aural discharge), respiratory (tracheal/endobronchial stenosis/obstruction), laboratory involvement and higher frequency of conductive hearing loss than in this paediatric series. CONCLUSIONS: Paediatric patients compared to adults with GPA/WG have similar pattern of clinical manifestations but different frequencies of organ involvement.

Ann and Robert H Lurie Children's Hospital of Chicago Chicago IL USA

Asklepios Klinik Altona Hamburg Germany

Benghazi Children Hospital Benghazi MUB Rheumatology Clinic Benghazi Lybia

Charles University Prague 1st Medical Faculty and General University Hospital Prague Prague Czech Republic

CHU Le Kremlin Bicêtre APHP University of Paris Sud CEREMAI Le Kremlin Bicêtre Paris France

Department of Allergology Rheumatology and Clinical Immunology University Children's Hospital University Medical Centre Ljubljana Ljubljana Slovenia

Department of Pediatric Immunology and Rheumatology Wilhelmina Kinderziekenhuis Utrecht Netherlands

Department of Pediatric Rheumatology and Immunology University Children's Hospital Muenster Germany

Department of Pediatric Rheumatology and Nephrology Hacettepe University Children's Hospital Ankara Turkey

Department of Pediatrics Division of Pneumology and Immunology Charité Universitätsmedizin Berlin Berlin Germany

Department of Pediatrics Emma Children Hospital AMC Amsterdam Netherlands

Department of Pediatrics Skejby Sygehus Aarhus University Hospital Pediatric Rheumatology Clinic Aarhus Denmark

Department of Pediatrics The Queen Silvia Children's Hospital University of Gothenburg Göteborg Sweden

Department of Rheumatology Great Ormond St Hospital NHS Foundation Trust London UK

Dipartimento di Pediatria Università degli Studi di Genova Genova Italy

Hamburger Zentrum für Kinder und Jugendrheumatologie Klinikum Eilbek Hs 6 Hamburg Germany

Hospital Dr Felipe Glasman Rheumatolgy Section Bahía Blanca Buenos Aires Argentina

Istituto Giannina Gaslini Nefrologia Genova Italy

Istituto Giannina Gaslini Pediatria 2 Reumatologia PRINTO Genova Italy

Istituto Giannina Gaslini Pediatria 2 Reumatologia PRINTO Genova Italy ; Charles University Prague 1st Medical Faculty and General University Hospital Prague Prague Czech Republic

Istituto Giannina Gaslini Pediatria 2 Reumatologia PRINTO Genova Italy ; Dipartimento di Pediatria Università degli Studi di Genova Genova Italy

Istituto Giannina Gaslini Servizio di Epidemiologia e Biostatistica Genova Italy

Juliane Marie Centret Rigshospitalet Pediatrisk klinik 2 Copenhagen Denmark

Kinderklinik Garmisch Partenkirchen gGmbH Deutsches Zentrum für Kinder und Jugendrheumatologie Garmisch Partenkirchen Germany

Pediatric Department University Hospital Centre Tirana Albania

Universidade Federal de São Paulo Pediatrics São Paulo Brazil

Université Paris Descartes Institut IMAGINE Hôpital Necker Enfants Malades Centre de référence national pour les Arthrites Juveniles Unité d'Immunologie Hématologie et Rhumatologie Pediatrique Paris France

See more in PubMed

Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts R. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Ann Rheum Dis. 2011;70:704. doi: 10.1136/ard.2011.150714. PubMed DOI

Mahr AD, Neogi T, Merkel PA. Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol. 2006;24:S82–S91. PubMed

Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Granulomatous vasculitis, giant cell arteritis and sarcoidosis. In: Textbook of pediatric rheumatology. Harcourt Health Science Company, editor. Sixth edition:315–343. Philadelphia, USA: W.B.Saunders Company; 2010.

Hellmich B, Lamprecht P, Gross WL. Advances in the therapy of Wegener's granulomatosis. Curr Opin Rheumatol. 2006;18:25–32. doi: 10.1097/01.bor.0000200369.24793.f5. PubMed DOI

Falk RJ, Jennette JC. Rituximab in ANCA-associated disease. N Engl J Med. 2010;363:285–286. doi: 10.1056/NEJMe1004992. PubMed DOI

Cabral DA, Uribe AG, Benseler S, O'Neil KM, Hashkes PJ, Higgins G, Zeft AS, Lovell DJ, Kingsbury DJ, Stevens A, McCurdy D, Chira P, Abramson L, Arkachaisri T, Campillo S, Eberhard A, Hersh AO, Huber AM, Kim S, Klein-Gitelman M, Levy DM, Li SC, Mason T, DeWitt EM, Muscal E, Nassi L, Reiff A, Schikler K, Singer NG, Wahezi D. et al.Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. Arthritis Rheum. 2009;60:3413–3424. doi: 10.1002/art.24876. PubMed DOI

Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221–232. doi: 10.1056/NEJMoa0909905. PubMed DOI PMC

Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van PP, Walsh D, Walsh M, Westman K, Jayne DR. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010;363:211–220. doi: 10.1056/NEJMoa0909169. PubMed DOI

Bosch X, Guilabert A, Espinosa G, Mirapeix E. Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA. 2007;298:655–669. doi: 10.1001/jama.298.6.655. PubMed DOI

Koldingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum. 2000;43:2481–2487. doi: 10.1002/1529-0131(200011)43:11<2481::AID-ANR15>3.0.CO;2-6. PubMed DOI

Mahr AD, Neogi T, LaValley MP, Davis JC, Hoffman GS, McCune WJ, Specks U, Spiera RF, St Clair EW, Stone JH, Merkel PA. Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis. Arthritis Rheum. 2008;59:884–891. doi: 10.1002/art.23707. PubMed DOI PMC

Dadoniene J, Pileckyte M, Baranauskaite A, Kirdaite G. Clinical characteristics and long-term outcomes of 35 patients with Wegener's granulomatosis followed up at two rheumatology centers in Lithuania. Medicina (Kaunas ) 2010;46:256–260. PubMed

Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, Hoffman GS. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr. 1993;122:26–31. doi: 10.1016/S0022-3476(05)83482-1. PubMed DOI

Belostotsky VM, Shah V, Dillon MJ. Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol. 2002;17:754–761. doi: 10.1007/s00467-002-0914-2. PubMed DOI

Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936–941. PubMed PMC

Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, Cuttica R, Khubchandani R, Lovell DJ, O'Neil KM, Quartier P, Ravelli A, Iusan SM, Filocamo G, Magalhaes CS, Unsal E, Oliveira S, Bracaglia C, Bagga A, Stanevicha V, Manzoni SM, Pratsidou P, Lepore L, Espada G, Paut IK, Zulian F, Barone P, Bircan Z, Maldonado MR, Russo R. et al.EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. Ann Rheum Dis. 2010;69:790–797. doi: 10.1136/ard.2009.116624. PubMed DOI

Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M. et al.EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69:798–806. doi: 10.1136/ard.2009.116657. PubMed DOI

Mina R, Brunner HI. Pediatric lupus–are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin North Am. 2010;36:53–80. doi: 10.1016/j.rdc.2009.12.012. PubMed DOI PMC

Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Smith M, Cintas HL, McGarvey CL, James-Newton L, Pokrovnichka A, Moini B, Cabalar I, Lovell DJ, Wesley R, Plotz PH, Miller FW, Hicks JE, Rider LG. Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford) 2009;48:134–139. PubMed PMC

Mahr A, Girard T, Agher R, Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology (Oxford) 2001;40:492–498. doi: 10.1093/rheumatology/40.5.492. PubMed DOI